Skip to main content
Công ty Cổ phần Dược phẩm Bến Tre logo

Công ty Cổ phần Dược phẩm Bến Tre — Investor Relations & Filings

Ticker · DBT ISIN · VN000000DBT6 HSX Manufacturing
Open in API
Filings indexed 413 across all filing types
Latest filing 2026-04-09 Director's Dealing
Country VN Viet Nam
Listing HSX DBT

About Công ty Cổ phần Dược phẩm Bến Tre

www.bepharco.com

Bepharco (Công ty Cổ phần Dược phẩm Bến Tre) is a pharmaceutical company established in 1963, with over 60 years of experience in the production and distribution of pharmaceutical products. The company specializes in a diverse range of offerings, including prescription drugs, health protection foods, and medical equipment. Key product areas include cardiovascular, digestive, and anti-allergy medications, as well as traditional medicine. Bepharco maintains an extensive distribution network across numerous provinces and cities, and exports its products globally. It is recognized for its commitment to quality and its strategic collaborations in pharmaceutical education and research.

Recent filings

Filing Released Lang Actions
DBT: Thông báo giao dịch cổ phiếu của người nội bộ Hoàng Xuân An
Director's Dealing Classification · 98% confidence The document is a formal notice of share transactions by an internal person (a board member and deputy general director) and related parties, detailing the number of shares sold, ownership percentages before and after, transaction method, and expected dates. This matches the definition of Director's Dealing (insider trades) rather than a company repurchase or major shareholding change. Therefore it is classified as a Director's Dealing.
2026-04-09 Vietnamese
DBT: Thông báo thay đổi nhân sự - Miễn nhiệm Phó Tổng Giám đốc
Board/Management Information Classification · 90% confidence The document is an official notice from Ben Tre Pharmaceutical JSC and includes a Board of Directors resolution regarding the dismissal/resignation of a Deputy General Director and changes in Board membership. It does not contain financial statements or earnings data but solely announces senior management and board changes. This matches the “Board/Management Information” category.
2026-04-08 Vietnamese
DBT: Thông báo về việc đề cử ứng cử thành viên HĐQT
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal notice to shareholders of Ben Tre Pharmaceutical JSC calling for nominations and candidacy for the company’s Board of Directors ahead of the upcoming Annual General Meeting. It is sent to shareholders to provide information and solicit their participation/votes in the meeting process. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to inform them of meeting matters and request their votes. It is not the AGM presentation itself, nor a report publication, nor a simple regulatory filing, but a solicitation/information statement for shareholder action.
2026-04-08 Vietnamese
DBT: Thông báo nhận được Đơn từ nhiệm thành viên HĐQT
Board/Management Information Classification · 95% confidence The document is a formal stock exchange disclosure announcing that a board member, Mr. Hoang Xuan An, has submitted his resignation and will be proposed for dismissal at the upcoming Annual General Meeting. This is clearly an announcement of a change in the company’s board of directors, fitting the Board/Management Information category.
2026-04-08 Vietnamese
DBT: Thông báo đường dẫn tài liệu họp ĐHĐCĐ thường niên năm tài chính 2025
Report Publication Announcement Classification · 85% confidence The document is an official notice to the securities regulator and stock exchange announcing that the Annual General Meeting materials for the 2025 fiscal year have been published online via a provided link. It does not contain the AGM presentation or materials themselves but merely announces their availability. Under the “menu vs. meal” rule, such brief notices pointing to attached or online reports are classified as Report Publication Announcements (RPA).
2026-04-08 Vietnamese
DBT: Nghị quyết HĐQT về việc mời họp và tài liệu ĐHĐCĐ thường niên năm tài chính 2025
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a formal disclosure by the Board of Directors of Ben Tre Pharmaceutical JSC announcing and inviting shareholders to the 2025 Annual General Meeting. It sets out the meeting date, venue, agenda items, and provides a link to the meeting materials. This corresponds to a proxy solicitation/information statement rather than an actual annual report, earnings release, or audit report. Therefore, it should be classified under Proxy Solicitation & Information Statement (PSI).
2026-04-07 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.